Given the known roles of STAT1 and TGFβ in modulating immune responses [52,53], the inhibition of these pathways by TCS9725 may influence tumor–immune interactions, potentially altering immune cell activation, infiltration, or suppression within the tumor microenvironment [53]. Here, STAT1 is linked to neoplasm.